BIOL - Biolase Inc Stock Price, Fair Value and News

$0.01+0.01 (+Infinity%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

BIOL Price Action

Last 30 days

-50%

Last 90 days

-85.7%

Trailing 12 Months

-99.4%

BIOL RSI Chart

BIOL Valuation

Market Cap

366.0K

Price/Earnings (Trailing)

-0.02

Price/Sales (Trailing)

0.01

EV/EBITDA

0.27

Price/Free Cashflow

-0.03

BIOL Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

BIOL Fundamentals

BIOL Revenue

Revenue (TTM)

46.0M

Rev. Growth (Yr)

-0.65%

Rev. Growth (Qtr)

-6.1%

BIOL Earnings

Earnings (TTM)

-16.0M

Earnings Growth (Yr)

68.88%

Earnings Growth (Qtr)

48.96%

BIOL Profitability

Operating Margin

34.44%

EBT Margin

-34.77%

Return on Equity

306.81%

Return on Assets

-58.87%

Free Cashflow Yield

-3.7K%

BIOL Investor Care

Shares Dilution (1Y)

1493.42%

Diluted EPS (TTM)

20.75

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	48.8M	46.1M	46.0M	0
2023	48.8M	50.8M	49.7M	49.2M
2022	41.2M	44.3M	46.8M	48.5M
2021	26.1M	32.3M	35.3M	39.2M
2020	32.3M	26.5M	24.4M	22.8M
2019	46.5M	43.0M	40.7M	37.8M
2018	46.1M	45.6M	45.7M	46.2M
2017	51.7M	50.5M	48.1M	46.9M
2016	48.6M	50.6M	52.6M	51.8M
2015	47.0M	48.7M	47.2M	48.5M
2014	53.4M	49.3M	49.7M	47.7M
2013	59.6M	61.7M	60.3M	56.4M
2012	50.6M	51.1M	51.8M	57.4M
2011	30.7M	36.5M	43.4M	48.9M
2010	0	37.1M	30.8M	24.6M
2009	0	0	0	43.3M

Get all data in R, Python etc through our Historical Stock Data APIs

About Biolase Inc

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, therapy pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production. It also manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces; and sells teeth whitening gel kits. The company sells its products through its field sales force and distributor network. The company was formerly known as BIOLASE Technology, Inc. and changed its name to BIOLASE, Inc. in 2012. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California.

CEO	Mr. John R. Beaver
WEBSITE	biolase.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	188

Biolase Inc Frequently Asked Questions

What is the ticker symbol for Biolase Inc? What does BIOL stand for in stocks?

BIOL is the stock ticker symbol of Biolase Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Biolase Inc (BIOL)?

As of Fri Nov 01 2024, market cap of Biolase Inc is 365.97 Thousand. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of BIOL stock?

You can check BIOL's fair value in chart for subscribers.

Is Biolase Inc a good stock to buy?

The fair value guage provides a quick view whether BIOL is over valued or under valued. Whether Biolase Inc is cheap or expensive depends on the assumptions which impact Biolase Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BIOL.

What is Biolase Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Nov 01 2024, BIOL's PE ratio (Price to Earnings) is -0.02 and Price to Sales (PS) ratio is 0.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. BIOL PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Biolase Inc's stock?

In the past 10 years, Biolase Inc has provided -0.775 (multiply by 100 for percentage) rate of return.